Developing an adverse drug reaction reporting system at a teaching hospital

Basic and Clinical Pharmacology and Toxicology

Volumn 102, Issue 4, 2008, Pages 408-411

  Baniasadi, Shadi ^a   Fahimi, Fanak ^a   Shalviri, Gloria ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; CARDIOVASCULAR AGENT; CEFTRIAXONE; CEFUROXIME; CENTRAL NERVOUS SYSTEM AGENTS; GASTROINTESTINAL AGENT; HEPARIN; HORMONE; INSULIN; ISONIAZID; LIDOCAINE; LOCAL ANESTHETIC AGENT; PACLITAXEL; PHENYTOIN; RIFAMPICIN;

ANAPHYLAXIS; APNEA; ARTICLE; CONTROLLED STUDY; CONVULSION; CYANOSIS; DISEASE SEVERITY; DRUG INDUCED DISEASE; DRUG SURVEILLANCE PROGRAM; DYSPNEA; ERYTHEMA; HEALTH CARE PERSONNEL; HEPATITIS; HUMAN; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MORBIDITY; NAUSEA; PHLEBITIS; PRIORITY JOURNAL; RASH; SERUM SICKNESS; SKIN APPENDAGE DISEASE; SKIN MANIFESTATION; STEVENS JOHNSON SYNDROME; TEACHING HOSPITAL; THROMBOCYTOPENIA; UNSPECIFIED SIDE EFFECT; VOMITING;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC AGENTS; ATTITUDE OF HEALTH PERSONNEL; CHILD; CHILD, PRESCHOOL; COMMUNICATION; FEMALE; GASTROINTESTINAL DISEASES; HOSPITALS, TEACHING; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; IRAN; MALE; MEDICATION ERRORS; MIDDLE AGED; PHYSICIAN-NURSE RELATIONS; PILOT PROJECTS; PROGRAM DEVELOPMENT; SEVERITY OF ILLNESS INDEX; SKIN DISEASES; TIME FACTORS;

EID: 40849119879     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2008.00217.x     Document Type: Article

References (17)

1. Murphy BM, Frigo LC. Development, implementation, and results of a successful multidisciplinary adverse drug reaction reporting program in a university teaching hospital. Hosp Pharm 1993 28 : 1199 204, 1240.
2. Troutman WG, Doherty KM. Comparison of voluntary adverse drug reaction reports and corresponding medical records. Am J Health Syst Pharm 2003 60 : 572 5.
3. Gholami K, Shalviri G, Zarbakhsh A, Daryabari N, Yousefian S. New guideline for tramadol usage following adverse drug reactions reported to the Iranian pharmacovigilance center. Pharmacoepidemiol Drug Saf 2007 16 : 229 37.
4. Thiessard F, Roux E, Miremont-Salame G, Fourrier-Reglat A, Haramburu F, Tubert-Bitter P et al. Trends in spontaneous adverse drug reaction reports to the French pharmacovigilance system (1986-2001). Drug Saf 2005 28 : 731 40.
5. Uppsala Monitoring Centre. Adverse Reaction Terminology. World Health Organization Collaborating Centre for International Drug Monitoring, Uppsala, Sweden, 2003.
6. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981 30 : 239 45.
7. Schumock GT, Thornton JP. Focusing on the preventability of adverse drug reactions. Hosp Pharm 1992 27 : 538.
8. Baniasadi S, Fahimi F, Mansouri D. Serum sickness-like reaction associated with cefuroxime and ceftriaxone. Ann Pharmacother 2007 41 : 1318 9.
9. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalised patients - a meta-analysis of prospective studies. JAMA 1998 279 : 1200 5.
10. American Society of Health-System Pharmacists. Suggested definitions and relationships among medication misadventures, medication errors, adverse drug events, and adverse drug reactions. Am J Health Syst Pharm 1998 55 : 165 6.
11. Somers A, Petrovic M, Robays H, Bogaert M. Reporting adverse drug reactions on a geriatric ward: a pilot project. Eur J Clin Pharmacol 2003 58 : 707 14.
12. Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1997 277 : 301 6.
13. Moore N, Lecointre D, Noblet C, Mabille M. Frequency and cost of serious adverse drug reactions in a department of general medicine. Br J Clin Pharmacol 1998 45 : 301 8.
14. Geisslinger G, Dormann H, Muth-Selbach U, Krebs S, Criegee-Rieck M, Tegeder I et al. Incidence and costs of adverse drug reactions during hospitalisation: computerised monitoring versus stimulated spontaneous reporting. Drug Saf 2000 22 : 161 8.
15. Vallano A, Cereza G, Pedros C, Agustí A, Danés I, Aguilera C et al. Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital. Br J Clin Pharmacol 2005 60 : 653 8.
16. Prosser TR, Kamysz PL. Multidisciplinary adverse drug reaction surveillance program. Am J Hosp Pharm 1990 47 : 1334 9.
17. Suh DC, Woodall BS, Shin SK, Hermes-De Santis ER. Clinical and economic impact of adverse drug reactions in hospitalized patients. Ann Pharmacother 2000 34 : 1373 9.